MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-40-0005083
Niyamba Pharmaceutical Private Limited - pharma in Satna, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.03 Cr
▲ 2% YoY
Net profit · FY 2025
₹90,171
Net margin 0.9%
EBITDA · FY 2025
₹98,101
EBITDA margin 0.9%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Niyamba Pharmaceutical Private Limited
Data last updated:
Niyamba Pharmaceutical Private Limited is a private limited company based in Satna, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24230MP2016PTC035563. Its GSTIN is 23AAECB7925N1ZE (Madhya Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Rahul Singh and Arti Soni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mig – 7 Navrang Park Birla Road Kolgawan, Satna, Madhya Pradesh, India – 485001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹90,171 (net margin 0.9%) and EBITDA of ₹98,101 (EBITDA margin 0.9%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 16% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
Niyamba Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-40-0005083). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website niyambapharma.com.
Company details
CIN U24230MP2016PTC035563
Registration Number 035563
Incorporation Date 17 March 2016
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-40-0005083
Recognitions & Rankings of Niyamba Pharmaceutical
Contact details
Niyamba Pharmaceutical Private Limited's registered office is in Satna, Madhya Pradesh. Its website is niyambapharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressMig – 7 Navrang Park Birla Road Kolgawan, Satna, Madhya Pradesh, India – 485001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Niyamba Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Niyamba Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Niyamba Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Niyamba Pharmaceutical Private Limited, buy the company report.
Financials of Niyamba Pharmaceutical Private Limited
FY 2025 filings availableNiyamba Pharmaceutical Private Limited reported revenue of ₹1.03 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹1.03 Cr ▲ 2%
Net profit · FY 2025
₹90,171 margin 0.9%
EBITDA · FY 2025
₹98,101 margin 0.9%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▲ 10%
5 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 29%
3 years · compounded
▼ 16%
5 years · compounded
▼ 7%
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 2% growth in the latest year. EBITDA rose 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹98,101 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹90,171 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.9% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Niyamba Pharmaceutical Private Limited, buy the company report.
Board of directors of Niyamba Pharmaceutical Private Limited
Niyamba Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rahul Singh | Director | 05 Mar 2022 | 4 Years 7 Months | Current |
| Arti Soni Also directs: Anant Webtech Private Limited, Aks IT Universe Private Limited | Director | 21 Apr 2017 | 9 Years 6 Months | Current |
| Prema Singh Gaharwar | Director | 21 Apr 2017 | 9 Years 6 Months | Current |
Peer comparison
Niyamba Pharmaceutical Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genex Laboratories Private Limited | ₹1.04 Cr (FY 2025) | -85.0% | Hyderabad, Telangana, India | |||
| Niyamba Pharmaceutical Private Limitedthis company | ₹1.03 Cr (FY 2025) | ₹90,171 | 0.9% | 2.0% | Satna, Madhya Pradesh, India | |
| Pfleger Healthcare Private Limited | ₹1.03 Cr (FY 2025) | 38.0% | Nashik, Maharashtra, India | |||
| Medill Pharma Private Limited | ₹1.03 Cr (FY 2025) | 23.0% | Jaipur, Rajasthan, India |
To see the full peer comparison of Niyamba Pharmaceutical Private Limited, buy the company report.
Auditor
Niyamba Pharmaceutical Private Limited is audited by MOHIT KHATWANI & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MOHIT KHATWANI & CO. | FY 2023 | 021031C |
Shareholding
The shareholding of Niyamba Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Niyamba Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2019 | 100312790 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Niyamba Pharmaceutical Private Limited has 1 court case on record: 1 filed by Niyamba Pharmaceutical. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Satna, Madhya Pradesh | Court case (RCS B) | Filed by the company against Amit Shrivastava Prop. M/S Cure and Care | Disposed |
To see the full case history of Niyamba Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Niyamba Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Niyamba Pharmaceutical has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAECB7925N1ZE | Madhya Pradesh | Active | 01 Jul 2017 |
| 23AAFCN2025C1Z7 | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Niyamba Pharmaceutical Private Limited, buy the company report.
Recent activity
Niyamba Pharmaceutical Private Limited has 5 board changes on record since 2016: 4 appointments and 1 cessation. The latest: Rahul Singh was appointed as Director on 05 Mar 2022.
AGM
Niyamba Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Niyamba Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Rahul Singh was appointed as Director.
Charges
A charge with Others amounted to Rs. 10.00 Lakh with Charge ID 100312790 was registered on 12 Dec 2019.
Ceased
Prinsi Singh ceased to be Director.
Appointed
Arti Soni was appointed as Director.
Appointed
Prema Singh Gaharwar was appointed as Director.
Appointed
Prinsi Singh was appointed as Director.
Incorporation
17 Mar 2016
Niyamba Pharmaceutical Private Limited was registered on 17 Mar 2016 with Roc Gwalior & aged 10 years 7 months as per MCA records.
Frequently asked questions
Niyamba Pharmaceutical is an active private limited company based in Satna, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2016 (10+ years old) and is registered under CIN U24230MP2016PTC035563.
Niyamba Pharmaceutical has 3 current directors:
- Rahul Singh - Director
- Arti Soni - Director
- Prema Singh Gaharwar - Director
The latest financial statements of Niyamba Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Niyamba Pharmaceutical is 23AAECB7925N1ZE, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 23AAFCN2025C1Z7 (Madhya Pradesh).
The CIN (Corporate Identification Number) of Niyamba Pharmaceutical is U24230MP2016PTC035563. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Niyamba Pharmaceutical has 1 court case on record: 1 filed by the company.
Niyamba Pharmaceutical was incorporated on 17 March 2016, making it 10+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Niyamba Pharmaceutical by revenue are Genex Laboratories Private Limited, Pfleger Healthcare Private Limited, Medill Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rahul Singh was appointed as Director on 05 Mar 2022. Prinsi Singh ceased to be Director on 18 May 2017. Arti Soni was appointed as Director on 21 Apr 2017. Niyamba Pharmaceutical has 5 board changes on record in total.
Yes, Niyamba Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-40-0005083).
Niyamba Pharmaceutical can be reached through the website niyambapharma.com. Its registered office is in Satna, Madhya Pradesh, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages